Sugarloaf Wealth Management, LLC Gritstone Bio, Inc. Transaction History

Sugarloaf Wealth Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$1.19 - $2.26 $3,151 - $5,984	-2,648 Reduced 44.33%	3,325 $5,000
Q2 2023 Jul 13, 2023	BUY	$1.66 - $3.03 $406 - $742	245 Added 4.28%	5,973 $11,000
Q4 2022 Feb 03, 2023	BUY	$2.17 - $3.92 $3,639 - $6,573	1,677 Added 41.4%	5,728 $19,000
Q3 2022 Oct 11, 2022	SELL	$2.46 - $4.75 $4,329 - $8,360	-1,760 Reduced 30.29%	4,051 $11,000
Q2 2022 Jul 12, 2022	BUY	$1.77 - $4.34 $10,285 - $25,219	5,811 New	5,811 $14,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Sugarloaf Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sugarloaf Wealth Management, LLC with notifications on news.